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Abstract 
Background: Protozoa in the genus Babesia are transmitted to humans through tick bites and cause babesiosis, a 
malaria-like illness. Vertical transmission of Babesia spp. has been reported in mammals; however, the exact timing 
and mechanisms involved are not currently known. The aims of this study were to evaluate the success of vertical 
transmission of B. microti in female mice infected before pregnancy (mated during the acute or chronic phases of 
Babesia infection) and that of pregnant mice infected during early and advanced pregnancy; to evaluate the pos-
sible influence of pregnancy on the course of parasite infections (parasitaemia); and to assess pathological changes 
induced by parasitic infection.
Methods: The first set of experiments involved two groups of female mice infected with B. microti before mating, and 
inseminated on the 7th day and after the 40th day post infection. A second set of experiments involved female mice 
infected with B. microti during pregnancy, on the 4th and 12th days of pregnancy. Blood smears and PCR targeting 
the 559 bp 18S rRNA gene fragment were used for the detection of B. microti. Pathology was assessed histologically.
Results: Successful development of pregnancy was recorded only in females mated during the chronic phase of 
infection. The success of vertical transmission of B. microti in this group was 63%. No evidence of pregnancy was 
found in females mated during the acute phase of infection or on the 4th day of pregnancy. In the group infected on 
the 12th day of pregnancy, numerous complications including loss of pregnancy and stillbirths were recorded. During 
the acute phase of infection, parasitaemia was lower in pregnant females in comparison to infected, non-pregnant 
control females.
Conclusions: Acute B. microti infection prevents the initiation of pregnancy and embryonic development if it occurs 
during the first trimester, and causes severe complications in foetal BALB/c mice in the second and third trimesters of 
pregnancy. Chronic B. microti infection has no detrimental impact on the initiation and development of pregnancy, but 
results in congenital infection of the offspring. Further study is required to determine the extent to which maternal anti-
babesial immune responses contribute to compromise pregnancy in the murine model of congenital Babesia infection.
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Background
Parasitic infections may have negative effects on host 
breeding success and the health of offspring born to 
infected mothers. Congenital parasitic infection is 
acquired when parasites are transmitted from an infected 
pregnant female to her offspring, and result in an infec-
tion that persists after birth [1]. Among the best-recog-
nised congenitally acquired parasite infections are those 
of Toxocara canis in dogs, Toxoplasma gondii, Trypano-
soma cruzi, Babesia microti, and Plasmodium sCns [1–5].
Protozoa in the genus Babesia are responsible for babe-
siosis, a malaria-like disease in humans and animals [6]. 
Acute babesiosis can lead to death, but asymptomatic/
subclinical infections have also been reported from 
humans and animals [7, 8]. Asymptomatic infections in 
females may have impacts on breeding and result in con-
genital infections in their offspring [9–11]. Congenitally 
acquired babesiosis has been reported for several Babe-
sia spp. and has been recognised in humans [1], livestock 
[12–15], and dogs [16, 17]. Congenital infection has 
also been reported in wild rodents that serve as reser-
voir hosts of these parasites [9, 18], as an example in B. 
microti in mice [19], and experimental studies have sup-
ported a vertical route of transmission for Babesia gib-
soni in dogs [20].
Reported cases of inborn babesiosis differ in their out-
comes. Congenital infections in voles, Microtus spp., 
and Peromyscus leucopus are subclinical [9, 18], while 
infections in dogs result in stillbirths and/or pathology 
and hence severe disease [16, 17, 20]. There may also be 
severe consequences in livestock, as in the case of a new-
born calf infected congenitally with Babesia bovis which 
died without treatment within 24 h of delivery [12].
The course of vertically transmitted babesiosis in off-
spring is highly dependent on the phase of the infection 
in mothers, and may differ between host species [19]. 
In our earlier work female mice with chronic infections 
gave birth to pups with asymptomatic, congenital infec-
tions, while those in the acute phase did not deliver any 
offspring [19]. In humans, 13 cases of congenital babe-
siosis due to B. microti have been reported to-date [1, 
21–29]. In all cases, the symptoms of the disease (flu-
like symptoms, anaemia, and hepatomegaly) in children 
occurred several weeks after delivery [1, 21–29]. In order 
to prevent and effectively treat congenital babesiosis, it 
is necessary to understand the mechanisms of vertical 
transmission (i.e. exact place, time, pathogenesis) and the 
consequences of parasitic infection acquired at different 
phases of pregnancy.
The aims of this study were (1) to evaluate and com-
pare the success of vertical transmission of B. microti in 
female mice infected before pregnancy (mated during the 
acute or chronic phase of Babesia infection) to that of 
pregnant mice infected during early and advanced preg-
nancy; (2) to evaluate the possible influence of pregnancy 
on the course of parasite infections (parasitaemia); and 
(3) to assess and compare pathological changes in female 
mice and their embryos induced by parasite infections.
Methods
Animals
Ten- to 12-week-old BALB/c mice, 82 females (experi-
mental and control groups) and 33 males (for mat-
ing only), were used in the course of the experiments 
(Table  1). All the animals were kept in standard cages 
provided with sawdust, nest material, food, and water 
ad libitum. Females were kept in cages in groups of 2–8 
before mating. Pregnant females and dams with pups 
were housed in pairs. The sire males were housed indi-
vidually while not paired with females, and then intro-
duced into cages with females for one night only (1 male 
+ 1–2 females). All of the procedures conducted on mice 
Table 1 Total number of females in the experimental and control groups, and number of embryos and pups recorded in the course of 
the experiments
Experiment I: females inseminated in acute (group A) and in chronic (group B) phase of B. microti infection. Experiment II: pregnant females infected in I (group C) and 
II (group D) trimester of pregnancy
NPI non-pregnant, infected, PU pregnant, uninfected, NPU non-pregnant, uninfected
* At the end of the experiment on a necropsy date
** In 3 females, 17 uterine scars were found, suggesting embryo implantation, but no further development
*** None of the 35 pups born in group D survived; NA not applicable, ND not done
Group Experiment I Experiment II Control groups
A B C D NPI PU NPU
Females 6 15 20 20 9 6 6
Pregnancies 0 14 3*,** 20 NA 6 NA
Embryos 0 65 0** 77 NA ND NA
Pups 0 52 0 35*** NA 41 NA
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were approved by the First Ethics Committee for Ani-
mal Experimentation in Poland (ethical license numbers: 
406/2013, 716/2015, and 536/2018), according to the 
principles governing experimental conditions and care of 
laboratory animals required by the European Union and 
the Polish Law on Animal Protection.
Babesia microti strain
Female mice were infected with the B. microti King’s 67 
strain, which originated from field voles in the Oxford 
area, United Kingdom [30]. The parasite was passaged 
from infected to naive mice by intraperitoneal injections 
of 5 ×  106 infected red blood cells (iRBCs) in a volume of 
0.2 ml [8, 19].
Mating and breeding of mice
Phases of the oestrous cycle in females were identi-
fied by crystal violet staining of vaginal smears [31]. 
The presence of a vaginal plug in the morning, follow-
ing introduction of males on the previous day, indicated 
that insemination had occurred. Around 8–12 days post 
fertilisation, females were weighed and vaginal smears 
were performed to determine whether pregnancy had 
been initiated by successful implantation. Females were 
housed in pairs during pregnancy. Pups developing from 
control group PU and from females mated during the 
chronic phase of infection (group B, see below: study 
design) were housed with their mothers until the end of 
the experiment.
Study design
The study design is presented in Fig.  1. The first set of 
experiments involved females infected with B. microti 
before mating. Females were assigned to two experimen-
tal groups:
In group A, six females in the appropriate phase of the 
reproductive cycle were mated on the 7th day post infec-
tion with B. microti (acute phase).
In group B, 15 females were mated during the chronic 
phase of B. microti infection, after the 40th day post 
infection (chronic phase).
A second set of experiments involved female mice 
infected with B. microti during pregnancy:
In group C, 20 fertilised females were infected with B. 
microti on the 4th day post mating, in early pregnancy.
In group D, 20 fertilised females were infected with 
B. microti on the 12th day post mating, in advanced 
pregnancy.
Three control groups of female mice were used, in total 
comprising 21 animals:
Control group 1 (NPI) of B. microti infection: nine vir-
gin females were infected with B. microti, to monitor the 
course of infection in non-pregnant females (non-preg-
nant, infected).
Control group 2 of pregnancy (PU): six fertilised unin-
fected females were used to monitor blood parameters 
and the course of pregnancy in healthy females (preg-
nant, uninfected).
Control group 3 (NPU): six non-pregnant, uninfected 
females provided baseline data for healthy females in the 
absence of infection.
Course of the experiments
Blood from the tip of the tail was collected for blood 
smears from each infected female, starting on the day of 
infection. From the 1st to 20th days post infection (dpi) 
(groups A, B, C, D, NPI), blood was collected every 2–4 
days. After the 20th day post infection (group B), samples 
were collected every 10 days (2–3 times: on 30th, 40th, 
and 50th days post infection) until insemination, which 
took place between the 40th and 50th days post infection, 
depending on the phase of the oestrus cycle of each indi-
vidual female.
At the end of the experiments all females were euthan-
ised by cervical dislocation. As the weight of females from 
group A had not changed since fertilisation, and ultra-
sound examination had been unable to detect any devel-
oping embryos, females from this group were necropsied 
on the 12th day to check on the state of pregnancy.
Females from group B were necropsied on the 12th (1 
female), 16th (3 females), and 18th (3 females) days of 
pregnancy, and after delivery—on the 1st (3 females), 7th 
(2 females), and 14th (3 females) days postpartum.
Females from group C were necropsied on the 8th (6 
females), 12th (6 females), 14th (6 females), and 18–20th 
(2 females) days of pregnancy.
Females from group D were necropsied between the 
14th and 18th days of pregnancy (2 females on 14th, 6 
females on 16th, 6 females on 18th), and 6 females on the 
1st day postpartum.
Six females from control group 1 (NPI, non-pregnant, 
infected) were necropsied on the 15th day post infec-
tion to collect samples for blood cell counts, histopa-
thology, and evaluation of parasitaemia. Another three 
mice, infected with B. microti to compare the course of 
parasitaemia with females from group B, were necropsied 
around the 150th day post infection.
Females from control group 2 (PU, pregnant, unin-
fected) were necropsied on the 1st (1 females), 7th (3 
females), and 14th (2 females) days postpartum.
Females from control group 3 (NPU, non-pregnant, 
uninfected) were necropsied at the age of 15 weeks—
around the same age as females from experimental 
groups A, C, and D (6 females).
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At necropsy of pregnant females, data on embryo 
development and tissue samples were collected for a 
range of laboratory investigations. Embryos (if present) 
were first collected from the uterus, washed twice in ster-
ile water, counted and weighed individually. The course 
of pregnancy, defined by the appropriate size and appear-
ance of embryos, was evaluated visually. Embryos were 
checked for the presence of developmental abnormali-
ties (i.e. malformation of limbs, evidence of stillbirth/
abortion).
Parameters and definitions:
“Initiation of pregnancy” was defined as successful 
implementation of embryos (presence of embryos or 
uterine scars).
“Mean litter size” was calculated as the mean number 
of collected pups/embryos per female in the group.
“Reproductive success” was calculated as the mean 
number of well-developed, normal embryos/pups per 
female in the group.
“Survival of offspring” was defined as the percentage of 
well-developed, live embryos/pups on the day of the nec-
ropsy from the total number of offspring born earlier.
“Vertical transmission” was expressed as the prevalence 
of B. microti infection (% B. microti-positive offspring) in 
the offspring of females from the experimental group, i.e. 
from infected mothers.
“Congenital infection” in the offspring refers to B. 
microti infection in the offspring acquired from an 
infected mother during the course of pregnancy.
Females from all experimental and control groups 
together with their offspring were necropsied. Blood 
samples (1 ml) were collected with a sterile syringe 
directly from the heart following the death of the females. 
B. microti
infection




Acute phase Chronic phase
x









Group C Group D
x
0 4              12 days post mating
First trimester Second trimester
Reproductive success    0%                                                           0%
mating
Fig. 1 Scheme of experiments. The first set of experiments involved females mated during the acute (group A) and chronic phases of B. microti 
infection (group B). A second set of experiments involved female mice infected with B. microti on the 4th (group C) and 12th (group D) days of 
pregnancy.
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Blood smears were prepared immediately for evaluation 
of parasitaemia (if the animal was infected), 100–200 µl 
of blood was kept frozen for DNA extraction, and the 
remaining blood sample was used for the determination 
of blood parameters: red blood cell (RBC) and platelets 
counts. Organs (brain, heart, lungs, kidneys, liver, spleen, 
uterus, placenta) were collected and weighed. A fragment 
of each organ was fixed in 10% formalin for histological 
examination and another fragment was frozen at a tem-
perature of –20 °C for DNA extraction.
Uteri were washed several times in sterile water. Tools 
were washed in sterile water, rinsed with alcohol, and 
flamed to remove eventual DNA contamination. At the 
necropsy of offspring, blood and selected tissue samples 
were collected for identification of congenital Babe-
sia infection. Large vessels in the foetuses/pups’ thorax 
were cut, and blood was collected using capillary tubes 
or micropipettes into spray-coated  K2EDTA tubes (2 ml, 
ProfiLab, Warsaw, Poland). At each stage of embryonic 
development (12th, 14th, 16th, 18th days of pregnancy) 
we were able to collect heart and lung samples; however, 
on the 12th and 14th days of pregnancy, those two organs 
were pooled due to their small size. From the 16th day of 
pregnancy, these organs were collected separately, but to 
maintain consistency the data are presented together, i.e. 
pooled, for these two organs. All organ types were possi-
ble to collect postpartum, if pups were in good condition 
(without malformations, not eaten by the mother, etc.). 
Each embryo was washed several times in sterile water, 
as were also all isolated organs. The latter were weighed; 
a fragment of each organ was then frozen at a tempera-
ture of –20 °C for DNA extraction. If available, fragments 




During pregnancy females were weighed every 2–4 days. 
Between the 12th and 18th days of pregnancy, ultra-
sound examinations were performed by an experienced 
veterinary practitioner to assess the status of pregnancy 
in groups B (n = 11), D (n = 10), and control group PU 
(n = 4), which were the only groups where we recorded 
advanced pregnancy. The examination was carried out 
with a MayLab One ultrasound transducer (Esaote, 
Genoa, Italy), with an 18 MHz line probe at a test depth 
of 3–4 cm. The study was performed along both the lon-
gitudinal and transverse axes of each animal. The mice 
were examined without anaesthesia (to avoid any impact 
on the embryos), after shaving the fur on the abdomen 
and applying ultrasound  Aquasonic®100 transmission gel 
for the ultrasound examination (Parker Laboratories, NY, 
USA), and were immobilised by scruffing (gripping the 
skin at the back of the neck). Examination was performed 
on the 12th, 14th, 16th, and 18th days of pregnancy. Lit-
ter size was estimated. Embryo heart rate was estimated 
during each monitoring session. Heart rate was meas-
ured in females and selected embryos (2–4 embryos, 
lying in a lateral position) from each female. The meas-
urements were performed using a probe with a frequency 
of 18 MHz, using spectral Doppler, by targeting a Dop-
pler gate (1 mm in diameter) at the heart. In the spectral 
Doppler, the distance between individual heartbeats was 
measured by manually overlaying gauges/markers (mini-
mum of two and maximum of five spectral Doppler beat 
measurements during each sweep), and then the average 
heart beat was calculated from the recorded values.
Monitoring of the course of B. microti infection
Parasitaemia was determined on the basis of  Hemacolor® 
(Merck, Darmstadt, Germany) stained blood smears 
as described previously [19]. A total of 20 or 200 fields 
during the acute or chronic phases of infection, respec-
tively, were inspected twice and the number of iRBCs was 
recorded. Parasitaemia was expressed as the percentage 
of infected cells.
Histological study and blood parameters
Histological specimens were examined as paraffin sec-
tions after staining by the haematoxylin-eosin method for 
evaluation of pathological changes in tissues [32]. Blood 
samples (0.25–0.5 ml) were collected from six females 
from each group into spray-coated  K2EDTA tubes (2 
ml, ProfiLab, Warsaw, Poland). RBC and platelet counts 
were performed by a commercial diagnostic laboratory 
(LabWet, Warsaw, Poland).
Detection of B. microti infection in females (experimental) 
and offspring (congenital)
Genomic DNA was extracted from blood and tissue sam-
ples of females, and from tissue samples of embryos and 
pups using a Qiagen  DNeasy® Blood & Tissue Kit (Qia-
gen, Hilden, Germany). Detection of B. microti was done 
by amplification and sequencing of the 559 bp fragment 
of 18S rRNA by PCR or nested-PCR (in the case of no, 
or weak, signal from the initial one-step PCR). The prim-
ers and thermal profiles used have been described previ-
ously [9, 19, 33]. Negative controls were performed with 
sterile water in the absence of template DNA. DNA of 
Babesia canis was used as positive control. PCR products 
were visualised following electrophoresis on 1.5% agarose 
gel, stained with Midori Green stain (Nippon Genetics, 
GmbH, Düren, Germany).
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Statistical analyses
The statistical approach has been documented compre-
hensively in our earlier publications [9, 19]. Analyses 
were carried out using SPSS v. 21.0. The Kruskal–Wallis 
H test with pairwise comparisons using Dunn’s test was 
used to compare reproductive success and blood counts 
between groups. The Mann–Whitney U test was used 
to compare the following parameters: percentage of B. 
microti-positive pups and embryos, survival of offspring, 
mean litter size, mean body mass, and mean heart rate 
between two groups.
Prevalence (percentage of animals infected) and verti-
cal transmission were analysed by maximum likelihood 
estimation based on log-linear analysis of contingency 
tables. For analysis of the prevalence of Babesia in pups, 
we fitted prevalence of Babesia infection as a binary fac-
tor (two levels: infected = 1, uninfected = 0), develop-
ment stage (two levels: embryo = 1, pup = 2), and age of 
pups (three levels: 1 = 1, 7 = 2, 14 = 3 days postpartum). 
Prevalence of B. microti is presented as a percentage of 
mice infected with 95% confidence interval  (CI95) calcu-
lated with bespoke software based on the tables of Rohlf 
and Sokal, by courtesy of F. S. Gilbert and J. M. Behnke 
[34].
A general linear model (GLM) was used for analysis 
of parasitaemia, which is reported as mean B. microti 
parasitaemia with standard error of the mean (SE). Mean 
parasitaemia of B. microti infection was calculated as the 
number of iRBCs/1000 RBCs. When samples were only 
positive by PCR, an intensity of 0.001 iRBC was imple-
mented into quantitative statistical analyses.
Results
Reproductive success of B. microti‑infected female mice
Female mice in control group PU showed no complica-
tions during pregnancy and pup delivery, with a mean lit-
ter size of 6.8 ± 1.0 (Tables 1,2). Ultrasound examination 
showed no malformations in embryos and all pups were 
delivered in good health and remained so until the day of 
necropsy (Table 2).
In Experiment I, the difference in reproductive success 
between groups A, B, and PU was significant (Kruskal–
Wallis test, H2 = 17.52, p < 0.001). Pairwise comparisons 
using Dunn’s test indicated that reproductive success in 
group PU was significantly higher than in group A (p < 
0.001), but not in group B (p > 0.05). Reproductive success 
was significantly higher in group B compared to group A 
(p = 0.0001, Fig. 1). In group A, no signs of implantation 
of embryos were observed during necropsy (Table 2). The 
proportion of pregnant females and reproductive suc-
cess in group B were similar to the results in the control 
group PU (Tables  1,2, not  significant, NS). Females in 
group B presented no evidence of complications during 
pregnancy; their mean body weight on the 18th day of 
pregnancy was similar to the mean weight of the females 
in the control group PU: 34.85 ± 4.01 g and 36.66 ± 0.88 
g, respectively (NS). Ultrasound examination showed 
normal pregnancy development; growth of embryos and 
their heart rates (beats/minute) were normal, and there 
were no significant differences in comparison to embryos 
of females from control group PU (205.96 ± 10.38/47.44 
± 4.84 vs 195.25 ± 13.15/47.23±5.14 on the 18th day of 
pregnancy, respectively).
The mean litter size was similar in groups B and PU 
(7.8 ± 0.9 vs 6.8 ± 1.0, respectively; NS, Table  2). Sur-
vival of offspring was 96% in group B (two embryos were 
found reabsorbed in the uterus of a female necropsied on 
the 18th day of pregnancy and three pups were killed by 
the dam between the 2nd and 4th days postpartum). Pups 
were asymptomatic and in good condition, no malforma-
tions were observed. Survival was similar to the survival 
of the offspring in the control group PU (Table  2). At 
the 14th day postpartum, the mean weight of pups from 
infected females from group B was similar to the mean 
weight of pups from uninfected females from control 
group PU (6.9 ± 0.2 g vs 6.8 ± 0.2 g respectively; NS).
In group C, infection with B. microti resulted in a total 
lack of embryos. No embryos (only uterine scars) were 
recorded during necropsy (undertaken between the 10th 
and 12th days of expected pregnancies). Uterine scars 
were found in only three females (15%) from this group, 
suggesting the implantation of 17 embryos in total.
In group D, females gained weight and showed no 
signs of complications until the 12th day of pregnancy 
(on the day of infection). The development of preg-
nancies until the 12th day of pregnancy was normal 
(living embryos recorded during ultrasound monitor-
ing in all females). The mean heart rate of embryos 
was similar to the mean heart rate of embryos from 
the control group PU (204.66 ± 7.44/39.36 ± 4.82 and 
197.04 ± 12.71/48.98 ± 4.62, respectively, NS). However, 
numerous complications appeared after infection with B. 
microti (Table  2). Ultrasound examination showed that 
embryos that were alive on the day of infection died on 
consecutive days post infection (between the 2nd and 
6th days post infection). The embryos’ hearts stopped 
beating and females had problems with delivery—pups 
were stillborn or died shortly after birth. As no living off-
spring were obtained from experimental groups C and D, 
females had no reproductive success (0% of live offspring) 
in comparison to the control group PU (100%; Fig.  1, 
Table 2).
On the 1st day postpartum, the combined mean 
weight of dead and live pups from group D was half the 
mean weight of the live pups from the control group PU 
(0.62 ± 0.08g vs 1.31 ± 0.13g; Mann–Whitney U test, 
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U13,13 = 142.0, p < 0.05). A number of visible malforma-
tions were recorded in embryos during necropsy of eight 
females from group D—limbs or heads of the embryos 
were in the process of reabsorption.
Vertical transmission of B. microti
Overall vertical transmission in group B was 63% [56–
70%] (Table 2). In group B, B. microti DNA was detected 
in 58% [Cl95: 46–69%] of embryos and 73% [57–86%] of 
pups (NS).
Interestingly, older pups showed significantly higher 
prevalence of infection than younger pups (Babesia 
infection × day postpartum: χ2 = 9.75, df = 2, p < 0.05). 
During the necropsies performed on the 1st day post-
partum, 43% [21–68%] of tested pups were B. microti-
positive; however, prevalence was higher on the 7th (88% 
[50–99%]) and 14th days postpartum (90% [68–98%]). 
There was no sex difference in the presence of congenital 
infection in pups—71% [46–88%] of males and 84% [68–
98%] of females tested positive (NS).
The detection of B. microti DNA in tissues of off-
spring and placentas from experimental groups B and D 
is shown in Table 3 (description further in the text). No 
clinical signs of the acute phase of the Babesia infection 
(dark-coloured urine, febrile seizures, anorexia, apa-
thy) were noted among the infected pups from group B 
(Table 2).
The DNA of B. microti was detected in 66% [59–72%] 
of tested offspring (67 positive/102 tested): 49% [38–61%] 
(34 positive/69 tested) in embryos and 100% [92–100%] 
(33/33) in examined pups (Mann–Whitney U test, U69,33 
= 561.0, p < 0.001, Table 3) from group D. The tissues of 
six embryos were in too poor condition to enable DNA 
extraction. As explained earlier, pups in this group were 
mostly stillborn, with visible head and/or limb malforma-
tions, or died a few hours after delivery.
There was no significant difference in the prevalence 
of infection between embryos from groups B and D (58% 
[46–69%] vs 49% [38–61%], respectively, NS). There was 
no significant difference in the detection of Babesia DNA 
in embryos necropsied during the second (on 12th and 
14th days of pregnancy) and third (on 16th and 18th days 
of pregnancy) trimesters of pregnancy. The percentage 
of infected pups in group D was higher than in group B 
on the 1st day postpartum (100% vs 43%, respectively, 
Mann–Whitney U test, U33,14 = 120.0, p < 0.001).
Table 2 Comparison of the reproductive success of females in experimental and control groups, and features of congenital B. microti 
infection in their offspring
NA not applicable, ND not enough material from resorbed embryos to perform molecular examination
Group Experiment I Experiment II Control group
A (n  = 6) B (n = 15) C (n = 20) D (n = 20) PU (n = 6)
Proportion of pregnant 
females  [Cl95] (n of preg-
nancies in the group/n 
of females in the group)
0% [0–41] (0/6) 93% [70–100] (14/15) 15% [4–37] (3/20) 100% [83–100] (20/20) 100% [92–100] (6/6)
Total n of offspring 0 117 17 112 41
Mean litter size ± SE (live 
+ dead)/group
0 7.8 ± 0.9 0.9 ± 0.5 5.6 ± 0.5 6.8 ± 1.0
Alive:dead offspring 0:0 112:5 0:17 0:112 41:0
Survival -% of alive 
embryos/pups  [Cl95], 
(infected/tested)
0% (0/0) 96% [92–98] (112/117) 0% (0/17) 0% 0/112 100% [93–100] (41/41)
Reproductive suc-
cess (mean n of alive 
offspring/n of females)
0.0 (0/6) 7.5 ± 0.9 (117/15) 0.0 (0/17) 0.0 (0/20) 6.8 ± 1.0 (41/6)
Vertical transmission  [Cl95], 
infected/tested
NA 63% [56–70] 71/112 ND 66% [59–72] 67/102 NA
Symptoms of infection 
in females during 
pregnancy
Apathy Asymptomatic Apathy, implantation 
scars in uteri, placentas 
in resorption
Apathy, difficulties during 
delivery
NA
Symptoms of infection in 
pups and embryos
NA Asymptomatic Resorption Developmental defects, 
stillbirth
NA
USG observation No visible preg-
nancy develop-
ment
Normal size of the 
embryos and 
embryo sacs
No visible pregnancy 
development
Following infection, ter-
mination of pregnancy 
was observed (death of 
embryos)
Normal size of the 
embryos and 
embryo sacs
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Babesia DNA was found in all types of tested organs 
(Table  3). A significantly higher percentage of positive 
samples was noted in the livers, spleens, kidneys and pla-
centas of offspring from group D in comparison to group 
B (Table 3).
Comparison of the course of B. microti infection in female 
mice
A comparison of the courses of B. microti infection 
during the acute and post-acute phases of infection 
in the experimental groups is presented in Fig.  2. In all 
experimental groups, the acute phase of B. microti infec-
tion was reflected in high parasitaemia during the first 
two weeks of infection. The highest parasitaemia was 
observed on the 7–8th dpi in all experimental and con-
trol groups (Fig. 2).
Parasitaemia on the 7–8th dpi was highest in control 
group NPI, lower in groups A and B, and lowest in groups 
C and D (group × parasitaemia on 7–8th dpi: F4,30= 2.79; p 
< 0.05; Fig. 2). Among experimental groups, maximum par-
asitaemia during the acute phase of infection was slightly 
higher in non-pregnant females in comparison to females 
Table 3 Occurrence of B. microti DNA in the tissue of embryos and pups, and placentas from experimental groups B and D.
NS not significant
Specimen tested Group B Group D Statistical values p values
% [95% Cl] Positive/tested % [95% Cl] Positive/tested
Blood 63% [56–70] 71/112 66% [59–72] 67/102 NS p  > 0.05
Brain 15% [6–21] 6/41 7% [0–30] 1/15 NS p  > 0.05
Heart and lungs 63% [56–70] 71/112 63% [50–75] 59/93 NS p  > 0.05
Liver 13% [7–23] 9/69 53% [29–78] 8/15 U = 309.0 p  < 0.05
Spleen 16% [7–32 7/44 63% [29–89] 5/8 U = 94.0 p  < 0.05
Kidneys 13% [5–29] 6/45 60% [33–81] 9/15 U = 180.0 p  < 0.05
Placenta 69% [53–82] 29/42 98% [93–100] 57/58 U = 876.0 p  < 0.001
Fig 2 The course of B. microti infection in experimental and control groups. Comparison of the course of B. microti infection  (Cl95) in mice pregnant 
in the different phases of the parasite infection. Level of B. microti parasitaemia on the selected day post infection. Parasitaemia is shown as a 
percentage of iRBCs found in mouse peripheral blood, measured on the Giemsa-stained thin smears. Data points are the mean for three to six 
animals.
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with confirmed pregnancy (55.4% vs 40.5%, respectively; 
pregnancy × parasitaemia: F4,42 = 7.97, p < 0.05).
No significant associations were observed between par-
asitaemia and success of vertical transmission or between 
parasitaemia and reproductive success of a female across 
the experimental groups.
Molecular detection of B. microti DNA in blood and tissue 
of females and dams
Statistical evaluation of the differences between treat-
ment groups in detection of B. microti DNA in blood 
and other tissues of females is presented in Table 4. The 
DNA of B. microti was found in blood samples collected 
from all infected females in experimental groups and 
from control group NPI (non-pregnant, infected). Babe-
sia DNA was identified in all tested organs (Table  4). 
The highest percentage of B. microti-positive tissues was 
detected in hearts and lungs, with the lowest in uteri.
Histopathological changes in female BALB/c mice
Material for histological examination was collected from 
selected females in experimental and control groups, 
and a variety of histopathological changes (lesions) were 
found in the organs of both experimental and control 
groups (Table 5). There was no significant effect of Babe-
sia infection on the frequency of lesions in the organs of 
the mothers. Some of the detected changes were associ-
ated with aging or development of pregnancy (results not 
shown).
Histopathological changes in offspring
Material for histological examination was collected 
from selected pups in experimental group B and control 
group PU on the 14th day postpartum. A variety of his-
topathological changes were found in the organs of pups 
from group B as well as in pups from control group PU 
(Table  6). There was no significant effect of B. microti 
infection on the occurrence of lesions in the organs of 
pups. Atrophy of cardiac myocytes occurred more fre-
quently in heart tissues in which B. microti DNA was 
detected in comparison to negative samples (4/6 = 67% 
vs 1/11 = 9%; χ 2 = 6.75, df = 1, p < 0.05), but no other 
statistical associations were found between the pres-
ence of infection (molecular detection) and pathological 
changes.
Blood parameters
As females from groups A and C presented no evidence 
of pregnancy, mean counts of RBCs and platelets from 
these groups were compared to the counts obtained from 
group NPU (non-pregnant, uninfected females) (Fig. 3a, 
b).
There was a significant difference in the RBC count 
between tested groups (Kruskal–Wallis test, H2 = 11.79; 
p < 0.05). Pairwise comparisons using Dunn’s test indi-
cated that the mean RBC count in group NPU was 
observed to be significantly higher from those of group A 
(p < 0.05) and group C (p < 0.05). No other significant dif-
ferences were observed between these groups.
There was a significant difference in the platelet count 
between tested groups A, C and NPU (Kruskal–Wallis 
test, H2 = 8.26; p < 0.05). Pairwise comparisons using 
Dunn’s test indicated that platelet counts in group NPU 
were observed to be significantly higher than in group C 
(p < 0.05) but not group A (NS). No other significant dif-
ferences were observed between these groups.
Mean blood counts of females in groups B and D 
were compared to the counts from group PU (pregnant, 
uninfected females) (Fig.  3a, b). There was a signifi-
cant difference in the RBC count between tested groups 
(Kruskal–Wallis test, H2 = 9.23; p < 0.05). The mean RBC 
count was significantly higher in group B in comparison 
to group D (p < 0.05). The mean RBC count (but not the 
platelet count) in the control group PU was twice as high 
as that in group D (p < 0.05, Fig. 3a). No other significant 
differences were observed between these groups.














Statistical values p values
Blood 100% [59–100] 100% [27–94] 100% [83–100%) 100% [83–100] 100% [59–100] NS p  > 0.05
Brain 67% [27–94] 53% [29–78] 70% [48–86] 100% [83–100] 100% [59–100] χ 2 = 3.97, df = 4 p  < 0.05
Heart 100% [59–100] 53% [29–78] 70% [48–86] 100% [83–100] 100% [59–100] χ 2 = 4.97, df = 4 p  < 0.05
Lungs 67% [27–94] 60% [33–81] 85% [63–96] 100% [83–100] 100% [59–100] χ 2 = 3.54, df = 4 p  < 0.05
Liver 67% [27–94] 27% [10–53] 35% [17–58] 90% [68–98] 100% [59–100] χ 2 = 8.29, df = 4 p  < 0.001
Spleen 67% [27–94] 40% [19–67] 60% [37–79] 100% [83–100] 100% [59–100] χ 2 = 6.18, df = 4 p  < 0.001
Kidneys 67% [27–94] 47% [22–71] 55% [32–76] 90% [68–98] 100% [59–100] χ 2 = 14.43, df = 4 p  < 0.05
Uterus 0% [0–41] 13% [2–40] 25% [10–48] 70% [48–86] 100% [68–100] χ 2= 10.30, df = 4 p  < 0.001
Page 10 of 17Tołkacz et al. Parasites Vectors          (2021) 14:132 
Table 5 Occurrence of pathological changes in organs and organ tissues of females from experimental groups.
Organ type Pathological 
changes








83% (5/6) 83% (5/6) 59% (10/17) 93% (14/15) 100% (4/4) 75% (3/4) NS p  > 0.05
Lymphoid hyper-
plasia
50% (3/6) 50% (3/6) 76% (13/17) 40% (6/15) 50% (2/4) 50% (2/4) NS p > 0.05
Presence of 
siderophages
50% (3/6) 83% (5/6) 6% (1/17) 47% (7/15) 0% (0/4) 50% (2/4) χ2 = 17.32, df 
= 5
p  < 0.05
Congestion 0% (0/6) 0% (0/6) 18% (3/17) 7% (1/15) 0% (0/4) 0% (0/4) NS p > 0.05




0% (0/6) 33% (2/6) 0% (0/17) 47% (7/15) 0% (0/5) 0% (0/4) NS p > 0.05
Hyperaemia 0% (0/6) 67% (4/6) 6% (1/17) 47% (7/15) 80% (4/5) 50% (2/4) χ2 = 21.40, df 
= 5
p  < 0.05
Necrosis of the 
hepatocytes
50% (3/6) 0% (0/6) 24% (4/17) 53% (8/15) 20% (1/5) 25% (1/4) NS p  >  0.05
Cholestasis in 
hepatocytes
0% (0/6) 83% (5/6) 12% (2/17) 13% (2/15) 0% (0/5) 50% (2/4) χ2 = 27.72, df 
= 5
p  < 0.001
Kidneys Necrosis of rental 
tubules




0% (0/6) 17% (1/6) 12% (2/17 20% (3/15) 0% (0/6) 25% (1/4) NS p  > 0.05
Acute nephritis 0% (0/6) 33% (2/6) 0% (0/17) 0% (0/15) 0% (0/6) 0% (0/4) NS p > 0.05
Glomerulone-
phritis
33% (2/6) 0% (0/6) 6% (1/17)) 0% (0/15) 17% (1/6) 25% (1/4) NS p > 0.05
Blood haemor-
rhages
0% (0/6) 17% (1/6) 0% (0/17) 27% (4/15) 33% (2/6) 0% (0/4) NS p > 0.05
Hyperaemia 17% (1/6) 50% (3/6) 24% (4/17) 40% (6/15) 67% (4/6) 0% (0/4) NS p > 0.05
Proteinuria 0% (0/6) 0% (0/6) 12% (2/17) 0% (0/15) 0% (0/6) 0% (0/4) NS p > 0.05
Parenchymatous 
degenera-
tion of rental 
tubules cells
33% (2/6) 67% (4/6) 76% (13/17) 80% (12/15) 100% (6/6) 0% (0/4) χ2= 18.43, df 
= 5
p  < 0.05
Brain Cerebral oedema 83% (5/6) 83% (5/6) 69% (11/16) 77% (10/13) 100% (6/6) 50% (2/4) χ2= 11.47, df 
= 5
p < 0.05





33% (2/6) 67% (4/6) 56% (9/16) 69% (9/13) 50% (3/6) 50% (2/4) NS p > 0.05
Nerve cells 
degeneration
33% (2/6) 17% (1/6) 6% (1/16) 46% (6/13) 0% (0/6) 25% (1/4) χ2= 16.08, df 
= 5
p < 0.05
Hyperaemia 0% (0/6) 33% (2/6) 0% (0/16) 0% (0/13) 33% (2/6) 0% (0/4) NS p > 0.05
Proliferation of 
microglia
0% (0/6) 0% (0/6) 13% (2/16) 15% (2/13) 0% (0/6) 25% (1/4) NS p > 0.05
Inflammation 0% (0/6) 0% (0/6) 6% (1/16) 0% (0/13) 0% (0/6) 0% (0/4) NS p > 0.05
Page 11 of 17Tołkacz et al. Parasites Vectors          (2021) 14:132  
No significant difference in the platelets count was 
found between groups B, D, and PU (Kruskal–Wallis test, 
H2 = 1.56; p = 0.459).
Discussion
Our experiments confirmed the negative influence of 
acute Babesia infection on the development of preg-
nancy and the reproductive success of BALB/c mice. In 
NS not significant
Table 5 (continued)
Organ type Pathological 
changes




Statistical values p value
Heart Necrosis of car-
diomyocytes




of the heart 
muscle
50% (3/6) 33% (2/6) 41% (7/17) 27% (4/15) 50% (3/6) 25% (1/4) NS p > 0.05
Focal fibrosis of 
myocardium
0% (0/6) 0% (0/6) 6% (1/17) 0% (0/15) 0% (0/6) 0% (0/4) NS p > 0.05
Congestion 
of the heart 
muscle









0% (0/6) 0% (0/6) 12% (2/17) 0% (0/15) 0% (0/6) 0% (0/4) NS p > 0.05
Lungs Atelectasis 50% (3/6) 100% (6/6 76% (13/17) 73% (11/15) 100% (6/6) 0% (0/4) χ2 = 29.08, df 
= 5
p < 0.001
Oedema 0% (0/6) 0% (0/6) 6% (1/17) 0% (0/15) 0% (0/6) 0% (0/4) NS p > 0.05
Emphysema 100% (6/6) 67% (4/6) 53% (9/17) 40% (6/15) 83% (5/6) 100% (4/4) χ2 = 14.45, df 
= 5
p < 0.05
Congestion 0% (0/6) 50% (3/6) 29% (5/17) 20% (3/15) 67% (4/6) 25% (1/4) NS p > 0.05
Necrosis 17% (1/6) 0% (0/6) 0% (0/17) 7% (1/15) 0% (0/6) 0% (0/4) NS p > 0.05





0% (0/6) 17% (1/6) 94% (16/17) 40% (6/15) 67% (4/6) 0% (0/4) NS p > 0.05
Uterus Blood haemor-
rhages in wall 
and mucous 
membrane
0% (0/3) 0% (0/6) 0% (0/16) 36% (5/14) 25% (1/4) 0% (0/4) NS p > 0.05
Hyperaemia 
of wall and 
mucous mem-
brane






0% (0/3) 50% (3/6) 69% (11/16) 43% (6/14) 25% (1/4) 25% (1/4) NS p > 0.05
Necrosis 0% (0/3) 0% (0/6) 0% (0/16) 7% (1/14) 0% (0/4) 0% (0/4) NS p > 0.05
Siderophages in 
myometrium




0% (0/3) 0% (0/6) 0% (0/16) 7% (1/14) 0% (0/4) 0% (0/4) NS p > 0.05
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this study, female mice that were inseminated during 
the acute phase of B. microti infection or shortly before 
implantation of embryos did not become pregnant. 
Infection during the second trimester of pregnancy also 
had a negative influence on the course of pregnancy, 
with stillbirth or death of pups shortly after delivery. 
However, in pregnancies that were initiated during the 
chronic phase of infection, infections had no detect-
able effect on the development of embryos or success of 
Table 6 Occurrence of pathological changes in tissues of pups from group B and control group PU on 14th day postpartum.
Organ Type of pathological changes group B (n = 18) Control group PU (n = 12) Statistical values
Spleen Extramedullary haematopoiesis 93% (13/14) 91% (10/11) NS
Lymphoid hyperplasia 57% (8/14) 91% (10/11) NS
Liver Inflammation 100% (18/18) 100% (12/12) NS
Congestion 83% (15/18) 50% (6/12) NS
Degeneration of the hepatocytes 6% (1/18) 8% (1/12) NS
Extramedullary haematopoiesis 50% (9/18) 42% (5/12) NS
Kidneys Necrosis of rental tubules epithelium 100% (18/18) 92% (11/12) NS
Congestion 61% (11/18) 50% (6/12) NS
Brain Cerebral oedema 94% (17/18) 100% (12/12) NS
Neuronophagia 6% (1/18) 25% (3/12) NS
Nerve cell (neuron) necrosis 28% (5/18) 42% (5/12) NS
Hyperaemia 22% (4/18) 17% (2/12) NS
Heart Necrosis of cardiomyocytes 44% (8/18) 83% (10/12) χ2 = 4.84, df = 1, 
p <  0.05
Inflammation of the heart muscle 61% (11/18) 67% (8/12) NS
Atrophy of cardiac myocytes 28% (5/18) 8% (1/12) NS
Congestion of the heart muscle 22% (4/18) 42% (5/12) NS
Lungs Atelectasis 100% (17/17) 91% (10/11) NS
Pneumonitis, interstitial inflammation 88% (15/17) 91% (10/11) NS
Emphysema 29% (5/17) 18% (2/11) NS
Congestion 47% (8/17) 45% (5/11) NS
Siderophages 6% (1/17) 0% (0/11) NS



























Fig 3 Comparison of the blood count results. a RBCs and b platelets in females mated on the 7th day post infection (group A), infected on the 4th 
day post mating (group C), in control group of infected, non-pregnant, uninfected females (NPU); in females mated after the 40th day post infection 
(group B), infected on the 12th day post mating (group D), and in control group of pregnant, uninfected females (UI). Whiskers indicate the lowest 
(lower) and the highest (upper) values.
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pregnancy, but were associated with a high degree of ver-
tical transmission of Babesia to the offspring.
When female mice were infected shortly before embryo 
implantation (groups A and C), either pregnancies failed 
to develop or the embryos were reabsorbed (presence of 
scars) in the first few days post insemination. We also 
observed a marked negative influence of B. microti infec-
tion on the development/outcome of more advanced 
pregnancies. Mice infected during the second trimester 
delivered infected pups (group D), which were unable to 
survive longer than one day post delivery, or pregnancy 
was terminated before delivery, as reflected in signs of 
embryo reabsorption at necropsy. This marked detri-
mental impact of infection on the initiation and course 
of pregnancy might be the consequence of intense para-
sitaemia and the resulting significant reduction in mater-
nal RBCs and platelets, leading to severe anaemia and 
thrombocytopenia. Babesia microti infection causes a 
reduction in RBC counts because of both sequestration 
of infected cells and disintegration of the iRBCs follow-
ing emergence of merozoites after intra-erythrocytic 
reproduction [35]. Acute babesiosis in women also leads 
to severe anaemia and thrombocytopenia if diagnosed 
in the second or third trimesters [36, 37]. Anaemia is a 
prominent symptom of babesiosis, and this was observed 
in females from groups A, C, and D during the initial 
and acute phases of infection (between 2nd and 20th 
days post infection). Advanced anaemia may play a role 
in the observed low reproductive success in experimen-
tal groups (i.e. because of limited oxygen transport to 
the developing foetuses). Our results have some similar-
ity to those of experimental infections with Plasmodium 
berghei and Plasmodium chabaudi AS in pregnant female 
mice, which resulted in low birth weights of pups, an 
increased frequency of abortions, and greatly increased 
foetal death rates [38, 39]. The marked detrimental 
impact of B. microti infection on the initiation, develop-
ment, and survival of pregnancies is consistent with the 
reported high mortality in children with congenital para-
sitic infections, mortality occurring between the 1st and 
30th days after birth if not treated for congenital toxo-
plasmosis, Chagas disease, and malaria [38, 40, 41]. Simi-
larly, in nonimmune pregnant women, malarial infection 
during the first or second trimester has been associated 
with frequent occurrence of spontaneous abortion [42]. 
Plasmodium vivax infections are also associated with an 
increased likelihood of miscarriage, the occurrence of 
intrauterine growth restriction [43], and lowered birth 
weight [44]. The results presented in the current study, 
in which females mated on the day of infection with B. 
microti did not deliver pups, are consistent with these 
findings [19].
In this study, the reproductive success of chronically 
infected females was much higher than in our previous 
study [19] and in a laboratory study of vertical trans-
mission of B. microti in P. leucopus. In the latter, 50% of 
female mice acquired B. microti infection via tick bites, 
and from these six infected individuals only three females 
produced offspring [10]. P. leucopus mice are a natural 
reservoir host of B. microti, which might be the reason 
that this species does not experience the same side effects 
and birth defects in the offspring as in the inbred Mus 
musculus BALB/c strain. To some extent our results may 
be the outcome of a different approach in study design 
in comparison to our previous experiments. More thor-
ough cytological examination in the current study, in 
comparison to our previous work, enabled us to increase 
the reproductive success by mating females exactly at the 
oestrus stage [19]. In our previous study, female repro-
ductive status was determined by visual assessment of 
the vaginal opening, and when assessed to be optimal was 
followed by introduction of male mice for a few consecu-
tive nights [19]. The procedural changes implemented in 
the current study may have increased the proportion of 
females that became pregnant. In the mice that became 
pregnant during chronic babesiosis (group B), we failed 
to observe any abnormalities in the reproductive suc-
cess or in the condition of offspring. Pups delivered by 
chronically infected females presented no manifesta-
tions of worsened condition (their heartbeat rate during 
pregnancy and birth weight were normal) in the current 
study, but also in our previous experiments, where only 
female mice in the post-acute and chronic phase of infec-
tion gave birth to viable offspring [19]. In another study, 
pups delivered by B. microti-infected P. leucopus females 
were born in good condition, and were able to reproduce 
and pass B. microti infection to the next generation of 
mice [10].
Parasites are known to employ a spectrum of evasive 
measures to avoid host immunity even when the host’s 
immune function is intact [11, 45, 46], and thus by facili-
tating persistent infection increase the probability of 
transmission. For example, the invasion of RBCs limits 
pathogen exposure. Expression of Babesia-induced adhe-
sion molecules on the RBC surface causes adherence of 
parasite-infected erythrocytes to the vascular endothe-
lium to avoid destruction in the spleen [11, 45–47]. As 
a result, an almost symbiotic relationship is created 
between the host’s immune system and the parasite, 
allowing the development of persistent infection [45]. On 
the other hand, chronic (“asymptomatic”) malaria has 
severe consequences for mothers and their newborns. 
While women with placental malaria have no obvious 
clinical signs of malaria infection during their pregnancy, 
there may be severe consequences at parturition and for 
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survival of the neonates. Circulating chronic infections 
are a major source of placental infection, associated with 
placental inflammation, fibrosis, and functional insuffi-
ciency, leading directly to miscarriage, preterm delivery, 
low birth weight, and peripartum haemorrhage and, thus, 
increased maternal and neonatal mortality [48–51].
Our previous study revealed that the success of vertical 
transmission was dependent on the phase of the infec-
tion in pregnant mice [19]. Since the circulation between 
the female and the foetus forms only on day 9 or 10 of 
gestation in mice, vertical transmission of parasites is not 
expected to occur earlier, ie. in the first trimester [1, 52]. 
It is possible that placental breaches/tears resulting from 
damage induced by placental inflammatory responses 
or appearing naturally close to the end of pregnancy, 
particularly during parturition, can facilitate congeni-
tal transmission of parasites from maternal blood [1]. 
The success of vertical transmission of B. microti in the 
current study was markedly lower than in our previous 
experiments [19]. This difference between studies may 
be linked to the time of blood collection and changes in 
maternal and individual immunity in pups. In the current 
experiment, blood samples were taken between the 12th 
day of pregnancy and 14th day postpartum. In our per-
vious experiments, blood samples were taken after the 
28th day postpartum [19]. Interestingly, human infants 
with congenital babesiosis develop symptoms (fever, 
fatigue, irritability, and decreased oral intake) and are 
admitted to hospital following 4-6 weeks postpartum [26, 
53]. A similar delay in the appearance of clinical signs 
of babesiosis has been observed in pups with congenital 
infections of B. canis—at 6 weeks, a period of life that 
is believed to be crucial in the development of immu-
nity in dogs [17]. During this period, maternally derived 
immunity decreases rapidly, to enable the development 
of individual immunity in the offspring [54]. It is possible 
that in the mouse model, an impaired maternal immune 
response gives B. microti an opportunity to multiply if 
individual immunity is not sufficiently intense.
Wild rodents that serve as hosts for B. microti usu-
ally present with very low parasitaemia (0.0001–0.004% 
RBCs), characteristic of chronic infections [9, 55, 56]. The 
course of parasitaemia in all the experimental groups was 
typical of B. microti infections in BALB/c mice, with a 
peak of parasitaemia between the 6th and 8th days post 
infection and an apparent clearance of circuiting iRBCs 
by the 30th to 40th days post infection [8, 19]. However 
this is not typical for reservoir host species in the wild 
[56]. Moreover, molecular examination in our study has 
provided evidence for prolonged low-intensity persistent 
infections even after blood smears were no longer detect-
ing iRBCs. These results may support the hypothesis of 
Bednarska et  al. [19], in which it was proposed that B. 
microti modulates the immune system, and when chronic 
infection is established and well stabilised in mice, the 
hormonal changes associated with the development of 
pregnancy do not affect or alter the course of infection. 
Further investigations, focusing on immunological and 
hormonal responses to B. microti infection during preg-
nancy, are required to fully clarify these relationships.
In our model, pregnancy and lactation during the 
chronic phase of infection did not change the level of 
parasitaemia significantly. It has been observed else-
where that some pregnant and lactating females in the 
post-acute phase of B. microti infection show minor 
increases in parasitaemia [19], but such modulation of 
the course of infection was not recorded in the current 
study. Haemoprotozoan parasitaemia levels in pregnant 
women/females appear to be an important factor con-
tributing to success of vertical transmission, e.g. congeni-
tal infections with T. gondii, T. cruzi, and P. falciparum 
occur more frequently in mothers displaying high levels 
of parasitaemia [1]. However, in our study there was no 
evidence to support the idea that the intensity of parasi-
taemia is a crucial factor in the success of vertical trans-
mission or reproductive success of infected mice.
The success of vertical transmission of B. microti in 
mice was high, regardless of the phase of infection in 
females. In other studies, vertically transmitted B. microti 
infection was detected in 81% of embryos of infected 
female voles [9] and in 74% of embryos and pups col-
lected from infected P. leucopus [10, 18], and 96% of pups 
delivered by infected mice were also infected [19]. In P. 
leucopus, B. microti infection lasted for over a year [10], 
and vertical transmission was possible for 11 months 
after infection of the females. Vertically infected P. leu-
copus females gave birth to offspring in which the prev-
alence of vertically acquired B. microti infection was 
38%. Despite the high efficiency of vertical transmission, 
vector-mediated transmission is still required for long-
term maintenance of B. microti in natural populations, 
because prevalence in offspring decreases over time [10]. 
It has been shown that vertically infected mice serve as a 
source of horizontal transmission to a feeding tick vector 
(61% feeding larvae and 58% of nymphs), and the infected 
ticks were able to infect susceptible hosts [10]. We know 
that at least until the 50th day post infection, BALB/c 
mice may give birth to vertically infected offspring. In 
this study, only the offspring from experimental group 
B could serve as a source of horizontal transmission to a 
feeding tick vector or for further studies of the efficiency 
of vertical transmission.
The DNA of B. microti was detected in all the tested 
organ tissues of females and their offspring. The highest 
percentage of B. microti-positive tissues in females was 
Page 15 of 17Tołkacz et al. Parasites Vectors          (2021) 14:132  
the placentas, hearts, and lungs, with the lowest percent-
age in the uteri, and in pups and embryos from groups 
B and D. The highest percentage of Babesia-infected tis-
sues was spleen, heart, and lungs. There was no differ-
ence in the detection of B. microti DNA in blood, brains, 
hearts, and lungs of pups and embryos from experimen-
tal groups B and D. These results suggest that the level 
of parasitaemia in mice does not influence the success of 
vertical transmission. Our study demonstrated that if the 
female is infected, the probability of successful transmis-
sion is high. The high frequency of parasite DNA detec-
tion in lungs and hearts of offspring from both groups 
may be associated with sequestration of iRBCs in lung 
capillaries, which has been observed previously during 
Babesia spp. infections [57]. The occurrence of cerebral 
infection was rare, regardless of the phase of maternal 
infection. In the case of liver, spleen, kidneys and also 
placentas, DNA detection was higher in offspring of 
females with a higher intensity of B. microti infection 
compared to the offspring of females in the chronic phase 
of infection, with parasitaemia close to zero. Despite 
these observations, no significant influence of the moth-
er’s parasitaemia on the success of vertical transmission 
was found. Sequestration of iRBCs in the spleens, lungs, 
and hearts has been described in bovines infected with B. 
bovis, and hamsters experimentally infected with Babe-
sia WA1 [58, 59]. High parasitaemia in placental blood, 
while lower in neonates, has been observed in malarial 
infections [4]. Poovassery and Moore described the accu-
mulation of P. chabaudi AS-infected erythrocytes in the 
placentas of infected mice as a manifestation of specific 
placental sequestration [39]. It is possible that placental 
accumulation is a phenomenon also observed in Babesia-
infected placental tissues, and future investigations will 
be necessary to elucidate the exact role of placental para-
sitaemia in congenital babesiosis.
The geographic range and the number of recorded 
cases of human babesiosis has lately increased [60], and 
this may be related to increasing prevalence of B. microti 
in its reservoir hosts and vectors [61, 62], in which ver-
tical transmission may play a role [9, 10, 18]. Increasing 
numbers of congenitally acquired human cases of babesi-
osis warrant further research on the nature of the mecha-
nisms of vertical transmission, and maternal and foetal 
immunological and hormonal response to infection in 
order to increase our understanding of these processes 
and to better inform our strategies for preventing and 
curing babesiosis more effectively in the future.
Conclusions
In conclusion, acute B. microti infection prevents the ini-
tiation of pregnancy and embryonic development dur-
ing the first trimester, and causes severe complications 
in foetal BALB/c mice in the second and third trimesters 
of pregnancy. Chronic B. microti infection has no det-
rimental impact on the initiation and development of 
pregnancy, but results in congenital infections of the off-
spring. Further study is required to determine the extent 
to which maternal anti-babesial immune responses con-
tribute to compromise pregnancy in the murine model of 
congenital Babesia infection.
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